Identification of genes that predict the response to chemotherapy with 5-azacytidine in myelodysplastic syndromes

被引：0
|
作者：
Matsumoto, Taichi [1 ,2 ]
Murakami, Yuichi [1 ]
Katsuchi, Daisuke [1 ]
Kuwano, Michihiko [1 ]
Ono, Mayumi [1 ,3 ]
机构：
[1] St Marys Inst Hlth Sci, Canc Transl Res Ctr, Fukuoka, Japan
[2] Fukuoka Univ, Dept Drug Inform, Pharm Sci, Fukuoka, Japan
[3] St Marys Coll, Grad Sch Nursing, Dept Pharm Oncol, Fukuoka, Japan
来源：
CANCER SCIENCE | 2023年 / 114卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-2366
引用
收藏
页码：1261 / 1261
页数：1
相关论文
共 50 条
  • [31] DNA and All-Trans Retinoic Acid as Immunotherapy or Add-on Adjuvants to 5-Azacytidine In Myelodysplastic Syndromes
    Le Pogam, Carole
    Krief, Patricia
    Beurlet, Stephanie
    Reboul, Murielle
    West, Robert
    Pla, Marika
    Charron, Dominique
    Fenaux, Pierre
    Chomienne, Christine
    Padua, Rose Ann
    BLOOD, 2010, 116 (21) : 1211 - 1211
  • [32] 5-Azacytidine modulates CpG methylation levels of EZH2 and NOTCH1 in myelodysplastic syndromes
    Gawlitza, Anja L.
    Speith, Johanna
    Rinke, Jenny
    Sajzew, Roman
    Mueller, Elena K.
    Schaefer, Vivien
    Hochhaus, Andreas
    Ernst, Thomas
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2019, 145 (11) : 2835 - 2843
  • [33] Response to 5-azacytidine in a patient with relapsed Hodgkin Lymphoma and a therapy-related myelodysplastic syndrome
    D'Alo, Francesco
    Leone, Giuseppe
    Hohaus, Stefan
    Teofili, Luciana
    Bozzoli, Valentina
    Tisi, Maria Chiara
    Rufini, Vittoria
    Calcagni, Maria Lucia
    Voso, Maria Teresa
    BRITISH JOURNAL OF HAEMATOLOGY, 2011, 154 (01) : 141 - 143
  • [34] Treatment of poor-risk myelodysplastic syndromes and acute myeloid leukemia with a combination of 5-azacytidine and valproic acid
    Kuendgen, Andrea
    Bug, Gesine
    Ottmann, Oliver G.
    Haase, Detlef
    Schanz, Julie
    Hildebrandt, Barbara
    Nachtkamp, Kathrin
    Neukirchen, Judith
    Dienst, Ariane
    Haas, Rainer
    Germing, Ulrich
    Gattermann, Norbert
    CLINICAL EPIGENETICS, 2011, 2 : 389 - 399
  • [35] ASXL1 mutations are associated with a response to alvocidib and 5-azacytidine combination in myelodysplastic neoplasms
    Riabov, Vladimir
    Xu, Qingyu
    Schmitt, Nanni
    Streuer, Alexander
    Ge, Guo
    Bolanos, Lyndsey
    Wunderlich, Mark
    Jann, Johann-Christoph
    Wein, Alina
    Altrock, Eva
    Demmerle, Marie
    Mukherjee, Sanjay
    Ali, Abdullah Mahmood
    Rapp, Felicitas
    Nowak, Verena
    Weimer, Nadine
    Oblaender, Julia
    Palme, Iris
    Goel, Melda
    Jawhar, Ahmed
    Darwich, Ali
    Wuchter, Patrick
    Weiss, Christel
    Raza, Azra
    Foulks, Jason M.
    Starczynowski, Daniel T.
    Yang, Feng-Chun
    Metzgeroth, Georgia
    Steiner, Laurenz
    Jawhar, Mohamad
    Hofmann, Wolf-Karsten
    Nowak, Daniel
    HAEMATOLOGICA, 2024, 109 (05) : 1426 - 1438
  • [36] RESPONSE TO 5-AZACYTIDINE OF LEUKEMIC BLAST CELLS IN SUSPENSION - A BIOLOGICAL PARAMETER ASSOCIATED WITH RESPONSE TO CHEMOTHERAPY
    WANG, C
    CURTIS, JE
    SENN, JS
    TRITCHLER, DL
    MCCULLOCH, EA
    LEUKEMIA, 1987, 1 (11) : 753 - 756
  • [37] The prognostic significance of chromosome 17 abnormalities in patients with myelodysplastic syndrome treated with 5-azacytidine: Results from the Hellenic 5-azacytidine registry
    Diamantopoulos, Panagiotis
    Koumbi, Dafni
    Kotsianidis, Ioannis
    Pappa, Vasiliki
    Symeonidis, Argiris
    Galanopoulos, Athanasios
    Zikos, Panagiotis
    Papadaki, Helen A.
    Panayiotidis, Panayiotis
    Dimou, Maria
    Hatzhnichael, Eleftheria
    Vassilopoulos, George
    Delimpasis, Susan
    Mparmparousi, Despoina
    Papageorgiou, Sotirios
    Variami, Eleni
    Kyrtsonis, Marie-Christine
    Megalakaki, Aekaterini
    Kotsopoulou, Maria
    Repousis, Panagiotis
    Adamopoulos, Ioannis
    Kontopidou, Flora
    Christoulas, Dimitrios
    Kourakli, Alexandra
    Tsokanas, Dimitrios
    Papoutselis, Menelaos Konstantinos
    Kyriakakis, Georgios
    Viniou, Nora-Athina
    CANCER MEDICINE, 2019, 8 (05): : 2056 - 2063
  • [38] Maintenance with 5-Azacytidine for Acute Myeloid Leukemia and Myelodysplastic Syndrome Patients
    Oran, Betul
    de Lima, Marcos
    Garcia-Manero, Guillermo
    Thall, Peter F.
    Lin, Ruitao
    Alousi, Amin M.
    Hosing, Chitra
    Kebriaei, Partow
    Popat, Uday
    Giralt, Sergio
    Ahmed, Sairah
    Shpall, Elizabeth J.
    Andersson, Borje S.
    Bashir, Qaiser
    Ciurea, Stefan O.
    Rezvani, Katy
    Woodworth, Glenda
    Champlin, Richard E.
    BLOOD, 2018, 132
  • [39] Successful treatment of donor cell derived myelodysplastic syndrome with 5-azacytidine
    Jennane, Selim
    El Haddad, Mariyam
    Mahtat, El Mehdi
    Doghmi, Kamal
    Mikdame, Mohammed
    ANNALES DE BIOLOGIE CLINIQUE, 2017, 75 (06) : 713 - 714
  • [40] DNA METHYLATION PROFILING IN PATIENTS WITH MYELODYSPLASTIC SYNDROME TREATED WITH 5-AZACYTIDINE
    Belickova, M.
    Jonasova, A.
    Vesela, J.
    Stara, E.
    Mrhalkova, A.
    Soukupova, J.
    Cermak, J.
    HAEMATOLOGICA, 2013, 98 : 74 - 74
12345